Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 93

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 93
---
 this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly from the above depending on numerous factors, including any unforeseen cash needs. Similarly, the priority of our prospective uses of proceeds will depend on business and market conditions. Accordingly, our management will have significant flexibility and broad discretion in applying the net proceeds of the offering. If any unforeseen event occurs or the business conditions change, we may use the proceeds of this offering differently from that described in this prospectus. To the extent that the net proceeds we receive from this offering are not immediately used for the above purpose, we intend to invest its net proceeds in short-term, interest-bearing bank deposits or debt instruments.

<div align='center'>49

DETERMINATION OF OFFERING PRICE</div>

Since Living Homeopathy’s Class A Ordinary Shares are not listed or quoted on any exchange or quotation system, the offering price of Living Homeopathy’s Class A Ordinary Shares was determined by Living Homeopathy and the underwriter and is based on an assessment of Living Homeopathy’s financial condition and prospects, comparable companies with similar sizes and businesses currently traded on U.S. capital markets, and the general condition of the securities market. It does not necessarily bear any relationship to Living Homeopathy’s book value, assets, past operating results, financial condition or any other established criteria of value. Although Living Homeopathy’s Class A Ordinary Shares are not listed on a public exchange, Living Homeopathy intends to obtain a listing on the Nasdaq Capital Market immediately after the closing of the offering.

The offering price stated on the cover page of this prospectus should not be considered an indication of the actual value of the Class A Ordinary Shares. That price is subject to change as a result of market conditions and other factors, including the depth and liquidity of the market for the Class A Ordinary Shares, investor perception of us and general economic and market conditions, and we cannot assure you that the Class A Ordinary Shares can be resold at or above the public offering price.

<div align='center'>50

DIVIDEND POLICY</div>

The Company declared cash dividends
of $325,078 and $1,503,204 during the years ended March 31, 2024 and 2023. Other than this, we have not declared or paid any cash dividends
on its capital shares in the years ended March 31, 2024 and 2023. We currently